SCHEMBL7965060

SCHEMBL7965060

N#CC(=Cc1cc(O)c(O)c(Br)c1)S(=O)(=O)c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.69
ALDH1A1 P00352 8/20 0.68
HPGD P15428 5/20 0.68
KDM4E B2RXH2 4/20 0.68
KMT2A Q03164 4/20 0.68
SMN1; SMN2 Q16637 3/20 0.68
PKM P14618 2/20 0.68
L3MBTL1 Q9Y468 2/20 0.68
MEN1 O00255 2/20 0.68
HSD17B10 Q99714 2/20 0.68
POLB P06746 1/20 0.68
GAA P10253 1/20 0.68
ALPG P10696 1/20 0.68
ALOX15 P16050 1/20 0.68
ALOX12 P18054 1/20 0.68
TDP1 Q9NUW8 1/20 0.68
MAPT P10636 2/20 0.45
LMNA P02545 2/20 0.43
NEK2 P51955 1/20 0.42
F2R P25116 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965058 1.00 EGFR (0.69) EGFRALDH1A1HPGDKDM4EKMT2A
SCHEMBL7965055 1.00 EGFR (0.69) EGFRALDH1A1HPGDKDM4EKMT2A
SCHEMBL7952426 0.88 EGFR (0.66) EGFRALDH1A1HPGDKDM4EKMT2A
SCHEMBL7952429 0.88 EGFR (0.66) EGFRALDH1A1HPGDKDM4EKMT2A
SCHEMBL7952422 0.88 EGFR (0.66) EGFRALDH1A1HPGDKDM4EKMT2A
SCHEMBL7962343 0.84 EGFR (0.62) EGFRALDH1A1HPGDKDM4EKMT2A
SCHEMBL7962340 0.84 EGFR (0.62) EGFRALDH1A1HPGDKDM4EKMT2A
SCHEMBL7962335 0.84 EGFR (0.62) EGFRALDH1A1HPGDKDM4EKMT2A
SCHEMBL8323329 0.84 EGFR (0.58) EGFRALDH1A1HPGDKDM4EKMT2A
SCHEMBL8323332 0.84 EGFR (0.58) EGFRALDH1A1HPGDKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US claimed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO disclosed